© Copyright Acquisition International 2024 - All Rights Reserved.

Article Image - Atlas Genetics Completes $20m Series C Fundraising
Posted 27th February 2015

Atlas Genetics Completes $20m Series C Fundraising

NULL

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Atlas Genetics Completes $20m Series C Fundraising
Image

Atlas Genetics Completes $20m Series C Fundraising

Atlas Genetics Ltd (“Atlas” or the “Company”), the ultra-rapid ‘test and treat’ molecular diagnostics company, announced the completion of a Series C financing, raising $20 million from a syndicate including existing investors and one new investor, RMI Partners.

New investor, RMI Partners, is a global life sciences venture capital firm, the largest in Eastern Europe. Existing investors include Novartis Venture Funds, Consort Medical plc, Johnson & Johnson Innovation – JJDC, Inc., LSP, BB Biotech Ventures and South West Ventures Fund. This newly announced financing follows on from the previously announced Series B fundraising of $25 million.

Atlas develops ultra-rapid point-of-care diagnostic tests for infectious diseases. The io® system is at an advanced stage of development and is expected to be launched in Europe with the first test for Chlamydia later this year. The Series C investment will be used to accelerate the launch of the io® system, initiate US clinical trials, and expand the menu of tests available initially in the STI (sexually transmitted infections) and HAI (hospital acquired infections) markets.

Dr John Clarkson, Chief Executive Officer of Atlas, commented: “We would like to thank our investors for their continued support and we are delighted to welcome RMI Partners to the syndicate. This is an exciting time for the Company as we prepare our first product, a test for the sexually transmitted infection Chlamydia, for launch in Europe later this year. The funds raised will enable us to commercialise our io® system and to build out a programme of much needed ‘test and treat’ assays in markets where time really does matter, both for the physician and for the patient.”

For more information about Atlas Genetics, please visit atlasgenetics.com.

Categories: Finance


You Might Also Like
Read Full PostRead - Eye Icon
CEO of the Month: USA
Innovation
29/06/2016CEO of the Month: USA

OCEANWORX is a global sports marketing, media production and distribution founded by international media authority David Jones in the year 2000

Read Full PostRead - Eye Icon
Switching From Corporation To LLC: 4 Things To Know
Corporate Social Responsibility
25/04/2023Switching From Corporation To LLC: 4 Things To Know

Business goals, partnerships, and management styles can change occasionally. When the directors and executives of an established corporation wish to enjoy a more flexible management style and profit allocation, switching to a limited liability company (LLC) st

Read Full PostRead - Eye Icon
The Impact of a Brexit on the European E-Money Market
Finance
23/06/2016The Impact of a Brexit on the European E-Money Market

Craig James, CEO at Neopay, discusses the potential impact and implications of a Brexit on the future development of this sector.

Read Full PostRead - Eye Icon
Shaping the Future in the Digital Age
Legal
06/02/2024Shaping the Future in the Digital Age

For the best part of the last two decades, Liliana Bakayoko has been a vital cog in the works when it comes to assisting national and international clients with matters of law.

Read Full PostRead - Eye Icon
Data Warehousing: What It Is and Why It Is Important
News
25/05/2022Data Warehousing: What It Is and Why It Is Important

Cloud-based technology is rapidly changing the way people do business throughout the world. Companies can execute their operations more swiftly and effectively thanks to this technology. Important company data such as client portfolios, merchandise, and employ

Read Full PostRead - Eye Icon
A Legal Support in Starting or Expanding Your Innovative Business in Italy
Innovation
06/09/2022A Legal Support in Starting or Expanding Your Innovative Business in Italy

For a few years now, Italy has introduced several measures aimed at incentivizing foreign investment in Italy, encouraging the growth of innovative startups. Since 2017, those who intend to invest in the venture capital of innovative startups can benefit from

Read Full PostRead - Eye Icon
Thinking Outside the Box
Leadership
13/08/2019Thinking Outside the Box

Rosenbaum IP is an outcome oriented intellectual property firm, specializing in IP portfolio asset value building. We caught up with AI’s Leading Complex Intellectual Property Attorney of the Year, Illinois and Rosenbaum IP’s Chairman & CEO, David G. Rosen

Read Full PostRead - Eye Icon
What Can Businesses Do to Improve Their Cash flow?
Finance
16/07/2021What Can Businesses Do to Improve Their Cash flow?

From overdue invoices to staying on top of bills, it is estimated that one in four companies in the UK struggle with cash flow at some point, with as many as 61% having issues on a regular basis.

Read Full PostRead - Eye Icon
Fourth Quarter Update: A 2015 Year End Round-Up
Finance
26/02/2016Fourth Quarter Update: A 2015 Year End Round-Up

Founded in 1982, Global Prior Art is an established leader which is widely known by its trademark “The Most Trusted Name in IP Research.”



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow